BioHealth News Archive
Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months NYSE:EBS
GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has…
Read More
Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers | BioSpace
GERMANTOWN, Md., Aug. 17, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to…
Read More
United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease | BioSpace
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food…
Read MoreFrancis Collins Relies on Science and Faith – WSJ
It takes no time for Francis Collins, the director of the National Institutes of Health, to recall the moment when he knew he wanted…
Read More
2020 Technology Showcase (NCI)
The 2020 Technology Showcase is going virtual! Reserve the afternoon of September 9th on your calendar for the 2020 Technology Showcase. The 4th annual event will…
Read More
Sign Up Now – August 26th EIR Feedback Session
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your complimentary…
Read More
Register Now! 2020 BioHealth Capital Region Forum
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations | BioSpace
Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer. As…
Read More
USM Maryland Momentum Fund Invests $250,000 in $3.5M Seed Round of miRecule Inc. – USM
Baltimore, MD. (Aug. 10, 2020) -- The University System of Maryland (USM) Momentum Fund has invested $250K in miRecule, an emerging biotech company with…
Read More
Emmes Announces its Role in Phase 1 COVID-19 Vaccine Trial | BioSpace
ROCKVILLE, Md., Aug. 12, 2020 /PRNewswire/ -- Emmes today announced that it provided the data and statistical analysis support for the Phase 1 clinical trial…
Read More
Emergent BioSolutions CEO on Johnson & Johnson, AstraZeneca vaccine partnerships
Emergent BioSolutions CEO Bob Kramer joined Jim Cramer on “Mad Money” to discuss the biopharmaceutical company’s role in the quest to bring a Covid-19…
Read More
Alexandria Real Estate Equities, Inc. at the Vanguard of the Life Science Ecosystem’s Rapid Scaling of COVID-19 Testing
PASADENA, Calif., Aug. 13, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering…
Read More
1500 EAST GUDE DRIVE ROCKVILLE, MARYLAND – AVAILABLE NOW 21,400 RSF OF FLEX / OFFICE SPACE
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office REIT, is the first and longest-tenured owner, operator, and developer uniquely focused on…
Read More
2020 Life Sciences Real Estate Outlook – JLL
Our annual cluster ranking profiles the top U.S. life sciences hubs and tracks the progress of the up-andcoming life sciencesmarkets that are fast becoming…
Read More
QIAGEN to continue successful growth strategy focused on execution and greater value creation after voluntary public takeover offer falls short
Venlo, The Netherlands, August 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it will continue to execute its successful growth strategy…
Read More